Theravance Biopharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Theravance Biopharma (TBPH) and Merus (MRUS)
Theravance Biopharma (TBPH) Receives a Hold From TD Cowen
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH)
Buy Rating Affirmed on Theravance Biopharma Amid Strong Q1 Performance and Promising Pipeline Prospects
Theravance Biopharma Analyst Ratings
Buy Rating Affirmed for Theravance Biopharma on Strong Portfolio Performance and Promising Drug Prospects
Analysts Have Conflicting Sentiments on These Healthcare Companies: Theravance Biopharma (TBPH), Voyager Therapeutics (VYGR) and Praxis Precision Medicines (PRAX)
Theravance Biopharma Analyst Ratings
Balancing Growth Prospects and Clinical Outcomes: Hold Rating on Theravance Biopharma
Positive Financial Trajectory and Future Prospects Prompt Buy Rating for Theravance Biopharma
Promising Growth and Profitability Prospects: A Buy Rating for Theravance Biopharma
Hold Rating on Theravance Biopharma Amidst Steady Growth and Positive Future Expectations
Analysts Are Bullish on These Healthcare Stocks: Theravance Biopharma (TBPH), BioMarin Pharmaceutical (BMRN)
HC Wainwright & Co. Reiterates Buy on Theravance Biopharma, Maintains $20 Price Target
Theravance Biopharma Analyst Ratings
SVB Securities Remains a Buy on Theravance Biopharma (TBPH)
HC Wainwright Adjusts Price Target on Theravance Biopharma to $20 From $19, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Theravance Biopharma, Raises Price Target to $20
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), ANI Pharmaceuticals (ANIP) and Theravance Biopharma (TBPH)